Strategic Acquisition Kantar Health was acquired by Cerner Corporation, signaling potential access to broader healthcare technology ecosystems and client bases. Leverage Cerner’s healthcare technology footprint to cross-sell data analytics, real-world evidence and commercialization services to integrated health systems and EHR users.

Life Sciences Focus Specialization in life sciences data, analytics and real-world evidence positions Kantar Health to support pharma and biotech clients across oncology and rare diseases. Target drug developers seeking launch optimization, safety demonstration and long-term value substantiation to accelerate market access.

Global Reach Recent leadership changes and partnerships across regions indicate an opportunity to win in international markets. Proactively engage with Global/Regional teams to offer scalable research and analytics solutions tailored for diverse regulatory environments and market access challenges.

Tech Enabled Adopted tech stack including MicroStrategy, Kubernetes and data/privacy tooling suggests readiness for advanced analytics, dashboards and scalable deployments. Offer AI-assisted insights, real-world data integration, and secure data workflows to enhance decision making for life sciences clients.

Growth Partnerships Multiple recent partnerships and industry reports collaborations (e.g., with Eternal Group, ShareChat, Moj) reflect a collaborative growth model. Propose joint go-to-market programs, sponsored research, and co-branded studies to expand reach in high-growth digital health and consumer health segments.